English
简体中文
Total: £ 56.28
Published Date: 2026-04-08 | Pages: 137 | Tables: 122 | Medical Care
The global Full-Service Clinical Research Organization (CRO) market was valued at US$ 24560 million in 2025 and is anticipated to reach US$ 42320 million by 2032, at a CAGR of 8.2% from 2026 to 2032.
Clinical Research Organization (CRO) is a service organization that provides support to the pharmaceutical and biotechnology industries in the form of outsourced pharmaceutical research services. Full-Service Clinical Research Organization offer a full range of services covering drug development from start to finish. Full-Service Clinical Research Organization offer all the services of regulatory affairs, site selection and activation, site management, monitoring, data management, logistics management, pharmacovigilance, biostatistics, medical writing, and project management.
The full-service Clinical Research Organization (CRO) market is driven by the growing demand for drug development and clinical trials due to the increasing prevalence of diseases, advancements in biotechnology, and the rising investment in healthcare research. Pharmaceutical and biotechnology companies are increasingly outsourcing clinical trial management to CROs to save time and costs, while ensuring compliance with regulatory standards. The complexity of clinical trials, particularly for novel therapies, has led to a rising need for specialized services such as patient recruitment, regulatory support, and data management. CROs are equipped with the expertise, infrastructure, and global reach to handle multi-phase and international studies, which accelerates the drug development process and brings treatments to market more quickly.
However, the full-service CRO market faces several challenges, including intense competition and pricing pressures. As more CROs enter the market, there is a growing need for differentiation in services, particularly in terms of specialized expertise and geographical coverage. The complex and ever-changing regulatory landscape poses another challenge, as CROs must constantly adapt to evolving requirements in different regions. Furthermore, the risk of delays in clinical trials, due to factors such as patient recruitment challenges, regulatory hurdles, or logistical issues, can undermine the profitability and timelines of CROs. Additionally, there is a continuous push to enhance data security and ensure the integrity of clinical trial data, which adds additional regulatory and operational complexity for these organizations.
Global Full-Service Clinical Research Organization (CRO) key players include IQVIA, Labcorp, Syneos Health, PPD, ICON, etc. Global top three players hold a share about 30%. North America is the largest market, with a share about 45%, followed by APAC and Europe, both have a share about 50 percent.
This report delivers a comprehensive overview of the global Full-Service Clinical Research Organization (CRO) market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Full-Service Clinical Research Organization (CRO). The Full-Service Clinical Research Organization (CRO) market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Full-Service Clinical Research Organization (CRO) market comprehensively. Regional market sizes by Type, by End Use, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Full-Service Clinical Research Organization (CRO) manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by End Use, and by region.
Market Segmentation
By Company
IQVIA
Labcorp
Syneos Health
PPD
ICON
PRA
Parexel
Medpace
Wuxi Apptec
EPS International
Worldwide Clinical Trials
CMIC
Premier Research
Courante Oncology
PROMETRIKA
Hangzhou Tigermed
Clinipace
Premier Research
Segment by Type
Clinical CRO
Preclinical CRO
Segment by End Use
Small Medium Enterprise
Large Enterprise
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by End Use, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Full-Service Clinical Research Organization (CRO) companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by End Use, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Clinical CRO
1.2.3 Preclinical CRO
1.3 Market by End Use
1.3.1 Global Full-Service Clinical Research Organization (CRO) Market Growth by End Use: 2021 vs 2025 vs 2032
1.3.2 Small Medium Enterprise
1.3.3 Large Enterprise
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Full-Service Clinical Research Organization (CRO) Market Perspective (2021–2032)
2.2 Global Full-Service Clinical Research Organization (CRO) Growth Trends by Region
2.2.1 Global Full-Service Clinical Research Organization (CRO) Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Full-Service Clinical Research Organization (CRO) Historic Market Size by Region (2021–2026)
2.2.3 Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Region (2027–2032)
2.3 Full-Service Clinical Research Organization (CRO) Market Dynamics
2.3.1 Full-Service Clinical Research Organization (CRO) Industry Trends
2.3.2 Full-Service Clinical Research Organization (CRO) Market Drivers
2.3.3 Full-Service Clinical Research Organization (CRO) Market Challenges
2.3.4 Full-Service Clinical Research Organization (CRO) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Full-Service Clinical Research Organization (CRO) Players by Revenue
3.1.1 Global Top Full-Service Clinical Research Organization (CRO) Players by Revenue (2021–2026)
3.1.2 Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Players (2021–2026)
3.2 Global Top Full-Service Clinical Research Organization (CRO) Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Full-Service Clinical Research Organization (CRO) Revenue
3.4 Global Full-Service Clinical Research Organization (CRO) Market Concentration Ratio
3.4.1 Global Full-Service Clinical Research Organization (CRO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Full-Service Clinical Research Organization (CRO) Revenue in 2025
3.5 Global Key Players of Full-Service Clinical Research Organization (CRO) Head Offices and Areas Served
3.6 Global Key Players of Full-Service Clinical Research Organization (CRO), Products and Applications
3.7 Global Key Players of Full-Service Clinical Research Organization (CRO), Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Full-Service Clinical Research Organization (CRO) Breakdown Data by Type
4.1 Global Full-Service Clinical Research Organization (CRO) Historic Market Size by Type (2021–2026)
4.2 Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Type (2027–2032)
5 Full-Service Clinical Research Organization (CRO) Breakdown Data by End Use
5.1 Global Full-Service Clinical Research Organization (CRO) Historic Market Size by End Use (2021–2026)
5.2 Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by End Use (2027–2032)
6 North America
6.1 North America Full-Service Clinical Research Organization (CRO) Market Size (2021–2032)
6.2 North America Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Full-Service Clinical Research Organization (CRO) Market Size by Country (2021–2026)
6.4 North America Full-Service Clinical Research Organization (CRO) Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Full-Service Clinical Research Organization (CRO) Market Size (2021–2032)
7.2 Europe Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (2021–2026)
7.4 Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size (2021–2032)
8.2 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (2021–2026)
8.4 Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Full-Service Clinical Research Organization (CRO) Market Size (2021–2032)
9.2 Latin America Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (2021–2026)
9.4 Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size (2021–2032)
10.2 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (2021–2026)
10.4 Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Full-Service Clinical Research Organization (CRO) Introduction
11.1.4 IQVIA Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.1.5 IQVIA Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Details
11.2.2 Labcorp Business Overview
11.2.3 Labcorp Full-Service Clinical Research Organization (CRO) Introduction
11.2.4 Labcorp Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.2.5 Labcorp Recent Development
11.3 Syneos Health
11.3.1 Syneos Health Company Details
11.3.2 Syneos Health Business Overview
11.3.3 Syneos Health Full-Service Clinical Research Organization (CRO) Introduction
11.3.4 Syneos Health Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.3.5 Syneos Health Recent Development
11.4 PPD
11.4.1 PPD Company Details
11.4.2 PPD Business Overview
11.4.3 PPD Full-Service Clinical Research Organization (CRO) Introduction
11.4.4 PPD Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.4.5 PPD Recent Development
11.5 ICON
11.5.1 ICON Company Details
11.5.2 ICON Business Overview
11.5.3 ICON Full-Service Clinical Research Organization (CRO) Introduction
11.5.4 ICON Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.5.5 ICON Recent Development
11.6 PRA
11.6.1 PRA Company Details
11.6.2 PRA Business Overview
11.6.3 PRA Full-Service Clinical Research Organization (CRO) Introduction
11.6.4 PRA Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.6.5 PRA Recent Development
11.7 Parexel
11.7.1 Parexel Company Details
11.7.2 Parexel Business Overview
11.7.3 Parexel Full-Service Clinical Research Organization (CRO) Introduction
11.7.4 Parexel Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.7.5 Parexel Recent Development
11.8 Medpace
11.8.1 Medpace Company Details
11.8.2 Medpace Business Overview
11.8.3 Medpace Full-Service Clinical Research Organization (CRO) Introduction
11.8.4 Medpace Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.8.5 Medpace Recent Development
11.9 Wuxi Apptec
11.9.1 Wuxi Apptec Company Details
11.9.2 Wuxi Apptec Business Overview
11.9.3 Wuxi Apptec Full-Service Clinical Research Organization (CRO) Introduction
11.9.4 Wuxi Apptec Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.9.5 Wuxi Apptec Recent Development
11.10 EPS International
11.10.1 EPS International Company Details
11.10.2 EPS International Business Overview
11.10.3 EPS International Full-Service Clinical Research Organization (CRO) Introduction
11.10.4 EPS International Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.10.5 EPS International Recent Development
11.11 Worldwide Clinical Trials
11.11.1 Worldwide Clinical Trials Company Details
11.11.2 Worldwide Clinical Trials Business Overview
11.11.3 Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Introduction
11.11.4 Worldwide Clinical Trials Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.11.5 Worldwide Clinical Trials Recent Development
11.12 CMIC
11.12.1 CMIC Company Details
11.12.2 CMIC Business Overview
11.12.3 CMIC Full-Service Clinical Research Organization (CRO) Introduction
11.12.4 CMIC Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.12.5 CMIC Recent Development
11.13 Premier Research
11.13.1 Premier Research Company Details
11.13.2 Premier Research Business Overview
11.13.3 Premier Research Full-Service Clinical Research Organization (CRO) Introduction
11.13.4 Premier Research Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.13.5 Premier Research Recent Development
11.14 Courante Oncology
11.14.1 Courante Oncology Company Details
11.14.2 Courante Oncology Business Overview
11.14.3 Courante Oncology Full-Service Clinical Research Organization (CRO) Introduction
11.14.4 Courante Oncology Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.14.5 Courante Oncology Recent Development
11.15 PROMETRIKA
11.15.1 PROMETRIKA Company Details
11.15.2 PROMETRIKA Business Overview
11.15.3 PROMETRIKA Full-Service Clinical Research Organization (CRO) Introduction
11.15.4 PROMETRIKA Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.15.5 PROMETRIKA Recent Development
11.16 Hangzhou Tigermed
11.16.1 Hangzhou Tigermed Company Details
11.16.2 Hangzhou Tigermed Business Overview
11.16.3 Hangzhou Tigermed Full-Service Clinical Research Organization (CRO) Introduction
11.16.4 Hangzhou Tigermed Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.16.5 Hangzhou Tigermed Recent Development
11.17 Clinipace
11.17.1 Clinipace Company Details
11.17.2 Clinipace Business Overview
11.17.3 Clinipace Full-Service Clinical Research Organization (CRO) Introduction
11.17.4 Clinipace Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.17.5 Clinipace Recent Development
11.18 Premier Research
11.18.1 Premier Research Company Details
11.18.2 Premier Research Business Overview
11.18.3 Premier Research Full-Service Clinical Research Organization (CRO) Introduction
11.18.4 Premier Research Revenue in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
11.18.5 Premier Research Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Clinical CRO
Table 3. Key Players of Preclinical CRO
Table 4. Global Full-Service Clinical Research Organization (CRO) Market Size Growth by End Use (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Full-Service Clinical Research Organization (CRO) Market Size by Region (US$ Million), 2021–2026
Table 7. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2021–2026)
Table 8. Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Full-Service Clinical Research Organization (CRO) Market Share by Region (2027–2032)
Table 10. Full-Service Clinical Research Organization (CRO) Market Trends
Table 11. Full-Service Clinical Research Organization (CRO) Market Drivers
Table 12. Full-Service Clinical Research Organization (CRO) Market Challenges
Table 13. Full-Service Clinical Research Organization (CRO) Market Restraints
Table 14. Global Full-Service Clinical Research Organization (CRO) Revenue by Players (US$ Million), 2021–2026
Table 15. Global Full-Service Clinical Research Organization (CRO) Market Share by Players (2021–2026)
Table 16. Global Top Full-Service Clinical Research Organization (CRO) Players by Tier (Tier 1, Tier 2, and Tier 3), based on Full-Service Clinical Research Organization (CRO) Revenue, 2025
Table 17. Ranking of Global Top Full-Service Clinical Research Organization (CRO) Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Full-Service Clinical Research Organization (CRO) Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Full-Service Clinical Research Organization (CRO), Headquarters and Area Served
Table 20. Global Key Players of Full-Service Clinical Research Organization (CRO), Products and Applications
Table 21. Global Key Players of Full-Service Clinical Research Organization (CRO), Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Full-Service Clinical Research Organization (CRO) Market Size by Type (US$ Million), 2021–2026
Table 24. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2021–2026)
Table 25. Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by Type (2027–2032)
Table 27. Global Full-Service Clinical Research Organization (CRO) Market Size by End Use (US$ Million), 2021–2026
Table 28. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2021–2026)
Table 29. Global Full-Service Clinical Research Organization (CRO) Forecasted Market Size by End Use (US$ Million), 2027–2032
Table 30. Global Full-Service Clinical Research Organization (CRO) Revenue Market Share by End Use (2027–2032)
Table 31. North America Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2021–2026
Table 33. North America Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size by Country (US$ Million), 2027–2032
Table 46. IQVIA Company Details
Table 47. IQVIA Business Overview
Table 48. IQVIA Full-Service Clinical Research Organization (CRO) Product
Table 49. IQVIA Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 50. IQVIA Recent Development
Table 51. Labcorp Company Details
Table 52. Labcorp Business Overview
Table 53. Labcorp Full-Service Clinical Research Organization (CRO) Product
Table 54. Labcorp Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 55. Labcorp Recent Development
Table 56. Syneos Health Company Details
Table 57. Syneos Health Business Overview
Table 58. Syneos Health Full-Service Clinical Research Organization (CRO) Product
Table 59. Syneos Health Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 60. Syneos Health Recent Development
Table 61. PPD Company Details
Table 62. PPD Business Overview
Table 63. PPD Full-Service Clinical Research Organization (CRO) Product
Table 64. PPD Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 65. PPD Recent Development
Table 66. ICON Company Details
Table 67. ICON Business Overview
Table 68. ICON Full-Service Clinical Research Organization (CRO) Product
Table 69. ICON Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 70. ICON Recent Development
Table 71. PRA Company Details
Table 72. PRA Business Overview
Table 73. PRA Full-Service Clinical Research Organization (CRO) Product
Table 74. PRA Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 75. PRA Recent Development
Table 76. Parexel Company Details
Table 77. Parexel Business Overview
Table 78. Parexel Full-Service Clinical Research Organization (CRO) Product
Table 79. Parexel Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 80. Parexel Recent Development
Table 81. Medpace Company Details
Table 82. Medpace Business Overview
Table 83. Medpace Full-Service Clinical Research Organization (CRO) Product
Table 84. Medpace Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 85. Medpace Recent Development
Table 86. Wuxi Apptec Company Details
Table 87. Wuxi Apptec Business Overview
Table 88. Wuxi Apptec Full-Service Clinical Research Organization (CRO) Product
Table 89. Wuxi Apptec Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 90. Wuxi Apptec Recent Development
Table 91. EPS International Company Details
Table 92. EPS International Business Overview
Table 93. EPS International Full-Service Clinical Research Organization (CRO) Product
Table 94. EPS International Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 95. EPS International Recent Development
Table 96. Worldwide Clinical Trials Company Details
Table 97. Worldwide Clinical Trials Business Overview
Table 98. Worldwide Clinical Trials Full-Service Clinical Research Organization (CRO) Product
Table 99. Worldwide Clinical Trials Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 100. Worldwide Clinical Trials Recent Development
Table 101. CMIC Company Details
Table 102. CMIC Business Overview
Table 103. CMIC Full-Service Clinical Research Organization (CRO) Product
Table 104. CMIC Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 105. CMIC Recent Development
Table 106. Premier Research Company Details
Table 107. Premier Research Business Overview
Table 108. Premier Research Full-Service Clinical Research Organization (CRO) Product
Table 109. Premier Research Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 110. Premier Research Recent Development
Table 111. Courante Oncology Company Details
Table 112. Courante Oncology Business Overview
Table 113. Courante Oncology Full-Service Clinical Research Organization (CRO) Product
Table 114. Courante Oncology Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 115. Courante Oncology Recent Development
Table 116. PROMETRIKA Company Details
Table 117. PROMETRIKA Business Overview
Table 118. PROMETRIKA Full-Service Clinical Research Organization (CRO) Product
Table 119. PROMETRIKA Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 120. PROMETRIKA Recent Development
Table 121. Hangzhou Tigermed Company Details
Table 122. Hangzhou Tigermed Business Overview
Table 123. Hangzhou Tigermed Full-Service Clinical Research Organization (CRO) Product
Table 124. Hangzhou Tigermed Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 125. Hangzhou Tigermed Recent Development
Table 126. Clinipace Company Details
Table 127. Clinipace Business Overview
Table 128. Clinipace Full-Service Clinical Research Organization (CRO) Product
Table 129. Clinipace Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 130. Clinipace Recent Development
Table 131. Premier Research Company Details
Table 132. Premier Research Business Overview
Table 133. Premier Research Full-Service Clinical Research Organization (CRO) Product
Table 134. Premier Research Revenue in Full-Service Clinical Research Organization (CRO) Business (US$ Million), 2021–2026
Table 135. Premier Research Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Full-Service Clinical Research Organization (CRO) Picture
Figure 2. Global Full-Service Clinical Research Organization (CRO) Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Full-Service Clinical Research Organization (CRO) Market Share by Type: 2025 vs 2032
Figure 4. Clinical CRO Features
Figure 5. Preclinical CRO Features
Figure 6. Global Full-Service Clinical Research Organization (CRO) Market Size by End Use (US$ Million), 2021–2032
Figure 7. Global Full-Service Clinical Research Organization (CRO) Market Share by End Use: 2025 vs 2032
Figure 8. Small Medium Enterprise Case Studies
Figure 9. Large Enterprise Case Studies
Figure 10. Full-Service Clinical Research Organization (CRO) Report Years Considered
Figure 11. Global Full-Service Clinical Research Organization (CRO) Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Full-Service Clinical Research Organization (CRO) Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Full-Service Clinical Research Organization (CRO) Market Share by Region: 2025 vs 2032
Figure 14. Global Full-Service Clinical Research Organization (CRO) Market Share by Players in 2025
Figure 15. Global Full-Service Clinical Research Organization (CRO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Full-Service Clinical Research Organization (CRO) Revenue in 2025
Figure 17. North America Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Full-Service Clinical Research Organization (CRO) Market Share by Country (2021–2032)
Figure 19. United States Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Full-Service Clinical Research Organization (CRO) Market Share by Country (2021–2032)
Figure 23. Germany Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Full-Service Clinical Research Organization (CRO) Market Share by Region (2021–2032)
Figure 31. China Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Full-Service Clinical Research Organization (CRO) Market Share by Country (2021–2032)
Figure 39. Mexico Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Full-Service Clinical Research Organization (CRO) Market Share by Country (2021–2032)
Figure 43. Israel Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Full-Service Clinical Research Organization (CRO) Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. IQVIA Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 47. Labcorp Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 48. Syneos Health Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 49. PPD Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 50. ICON Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 51. PRA Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 52. Parexel Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 53. Medpace Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 54. Wuxi Apptec Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 55. EPS International Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 56. Worldwide Clinical Trials Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 57. CMIC Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 58. Premier Research Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 59. Courante Oncology Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 60. PROMETRIKA Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 61. Hangzhou Tigermed Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 62. Clinipace Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 63. Premier Research Revenue Growth Rate in Full-Service Clinical Research Organization (CRO) Business (2021–2026)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
